Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence
Giuseppe Curigliano: The Path to A Successful Career
PRODIGE-13 Trial Results: Do We Really Need 5 Years of CT and CEA Follow-Up in CRC?
Vivek Subbiah: Why Traditional RCT-focused Reviews May Miss the Mark in Precision Medicine Era
Michelle Mitchell Welcomes Pete Markey as CRUK’s New Executive Director
Florian Scotté: Fast-Track Safety Evaluation in Anticancer Drug Development
Ophira Ginsburg: Thrilled to join Imperial College London’s School of Public Health
Arndt Vogel: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
